This is the authors' abstract. We don't add key points for this paper.
A highly efficient iron‐catalysed propargylation/alkyne oxacyclization/isomerization strategy is described. Biologically active furo[3,2‐c]coumarins and pyrano[3,2‐c]coumarins are expeditiously assembled in moderate to good yields and with a broad substrate scope. The regioselective access to different coumarins is mainly dependent on the terminal group of the secondary propargylic alcohol.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: